Trial intelligence / Profile preview

Impact of Topiramate on Almotriptan Efficacy in Migraine

NCT00210496Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Jun 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of topiramate in migraine, sponsored by Janssen Pharmaceutical. Started Jun 2005; status: completed.

02

Drugs

topiramate
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00210496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00210496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call